174 related articles for article (PubMed ID: 10946140)
1. Determination of the activity of ponazuril against Sarcocystis neurona in cell cultures.
Lindsay DS; Dubey JP; Kennedy TJ
Vet Parasitol; 2000 Sep; 92(2):165-9. PubMed ID: 10946140
[TBL] [Abstract][Full Text] [Related]
2. Efficacy of ponazuril 15% oral paste as a treatment for equine protozoal myeloencephalitis.
Furr M; Kennedy T; MacKay R; Reed S; Andrews F; Bernard B; Bain F; Byars D
Vet Ther; 2001; 2(3):215-22. PubMed ID: 19746664
[TBL] [Abstract][Full Text] [Related]
3. Prophylactic administration of ponazuril reduces clinical signs and delays seroconversion in horses challenged with Sarcocystis neurona.
Furr M; McKenzie H; Saville WJ; Dubey JP; Reed SM; Davis W
J Parasitol; 2006 Jun; 92(3):637-43. PubMed ID: 16884012
[TBL] [Abstract][Full Text] [Related]
4. High-throughput screen of drug repurposing library identifies inhibitors of Sarcocystis neurona growth.
Bowden GD; Land KM; O'Connor RM; Fritz HM
Int J Parasitol Drugs Drug Resist; 2018 Apr; 8(1):137-144. PubMed ID: 29547840
[TBL] [Abstract][Full Text] [Related]
5. Effect of intermittent oral administration of ponazuril on experimental Sarcocystis neurona infection of horses.
Mackay RJ; Tanhauser ST; Gillis KD; Mayhew IG; Kennedy TJ
Am J Vet Res; 2008 Mar; 69(3):396-402. PubMed ID: 18312139
[TBL] [Abstract][Full Text] [Related]
6. Therapeutics for Equine Protozoal Myeloencephalitis.
Pusterla N; Tobin T
Vet Clin North Am Equine Pract; 2017 Apr; 33(1):87-97. PubMed ID: 28161037
[TBL] [Abstract][Full Text] [Related]
7. Determination of the activity of pyrimethamine, trimethoprim, sulfonamides, and combinations of pyrimethamine and sulfonamides against Sarcocystis neurona in cell cultures.
Lindsay DS; Dubey JP
Vet Parasitol; 1999 Apr; 82(3):205-10. PubMed ID: 10348099
[TBL] [Abstract][Full Text] [Related]
8. Short communication: evaluation of the kinetics of antibodies against Sarcocystis neurona in serum from seropositive healthy horses without neurological deficits treated with ponazuril paste.
Pusterla N; Packham A; Wilson WD; White A; Bellamy P; Renier AC; Conrad PA
Vet Rec; 2013 Sep; 173(10):249. PubMed ID: 23893215
[No Abstract] [Full Text] [Related]
9. A review of Sarcocystis neurona and equine protozoal myeloencephalitis (EPM).
Dubey JP; Lindsay DS; Saville WJ; Reed SM; Granstrom DE; Speer CA
Vet Parasitol; 2001 Feb; 95(2-4):89-131. PubMed ID: 11223193
[TBL] [Abstract][Full Text] [Related]
10. An update on Sarcocystis neurona infections in animals and equine protozoal myeloencephalitis (EPM).
Dubey JP; Howe DK; Furr M; Saville WJ; Marsh AE; Reed SM; Grigg ME
Vet Parasitol; 2015 Apr; 209(1-2):1-42. PubMed ID: 25737052
[TBL] [Abstract][Full Text] [Related]
11. Drug treatment approved for equine neurological disease.
FDA Consum; 2001; 35(5):6. PubMed ID: 11697099
[No Abstract] [Full Text] [Related]
12. Selective inhibition of Sarcocystis neurona calcium-dependent protein kinase 1 for equine protozoal myeloencephalitis therapy.
Ojo KK; Dangoudoubiyam S; Verma SK; Scheele S; DeRocher AE; Yeargan M; Choi R; Smith TR; Rivas KL; Hulverson MA; Barrett LK; Fan E; Maly DJ; Parsons M; Dubey JP; Howe DK; Van Voorhis WC
Int J Parasitol; 2016 Dec; 46(13-14):871-880. PubMed ID: 27729271
[TBL] [Abstract][Full Text] [Related]
13. Equine protozoal myeloencephalitis.
Howe DK; MacKay RJ; Reed SM
Vet Clin North Am Equine Pract; 2014 Dec; 30(3):659-75. PubMed ID: 25441115
[TBL] [Abstract][Full Text] [Related]
14. Equine Protozoal Myeloencephalitis.
MacKay RJ; Howe DK
Vet Clin North Am Equine Pract; 2022 Aug; 38(2):249-268. PubMed ID: 35810151
[TBL] [Abstract][Full Text] [Related]
15. Determination of the activity of diclazuril against Sarcocystis neurona and Sarcocystis falcatula in cell cultures.
Lindsay DS; Dubey JP
J Parasitol; 2000 Feb; 86(1):164-6. PubMed ID: 10701584
[TBL] [Abstract][Full Text] [Related]
16. Equine Protozoal Myeloencephalitis: An Updated Consensus Statement with a Focus on Parasite Biology, Diagnosis, Treatment, and Prevention.
Reed SM; Furr M; Howe DK; Johnson AL; MacKay RJ; Morrow JK; Pusterla N; Witonsky S
J Vet Intern Med; 2016; 30(2):491-502. PubMed ID: 26857902
[TBL] [Abstract][Full Text] [Related]
17. Effect of a single dose of ponazuril on neural infection and clinical disease in Sarcocystis neurona-challenged interferon-gamma knockout mice.
Franklin RP; MacKay RJ; Gillis KD; Tanhauser SM; Ginn PE; Kennedy TJ
Vet Parasitol; 2003 May; 114(2):123-30. PubMed ID: 12781474
[TBL] [Abstract][Full Text] [Related]
18.
Hay AN; Witonsky SG; Lindsay DS; LeRoith T; Zhu J; Kasmark L; Leeth CM
J Parasitol; 2019 Apr; 105(2):371-378. PubMed ID: 31033388
[No Abstract] [Full Text] [Related]
19. Equine protozoal myeloencephalitis.
MacKay RJ; Granstrom DE; Saville WJ; Reed SM
Vet Clin North Am Equine Pract; 2000 Dec; 16(3):405-25. PubMed ID: 11219340
[TBL] [Abstract][Full Text] [Related]
20. Evidence to support horses as natural intermediate hosts for Sarcocystis neurona.
Mullaney T; Murphy AJ; Kiupel M; Bell JA; Rossano MG; Mansfield LS
Vet Parasitol; 2005 Oct; 133(1):27-36. PubMed ID: 15970386
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
